Description

The Tumor Test Marker YRA385 // YRA391 is an advanced diagnostic tool designed for chemiluminescence immunoassay analyzers, capable of detecting 18 distinct tumor markers. This product plays a pivotal role in early cancer detection by identifying elevated tumor marker levels in the blood, aiding in the diagnosis of various malignant tumors. Its sophisticated analysis mode, CLIA, ensures accurate results, making it an invaluable asset for healthcare professionals focused on oncological diagnostics.

Market Price

The Tumor Test Marker YRA385 // YRA391 is competitively priced in the market, typically ranging between $500 and $800 per kit, depending on the distributor and region. This price range reflects its advanced technology and the robustness of its diagnostic capabilities.

Frequently Asked Questions

What is the primary use of this test kit? The kit is used for early detection of cancer markers in the blood, assisting in diagnosing various cancers.

How many tests can each kit perform? Each kit is available in various package specifications, including 50T/BOX, 100T/BOX, and 24T/BOX, depending on laboratory needs.

Advantages and Disadvantages

Among the advantages of the Tumor Test Marker YRA385 // YRA391 are its accuracy, early detection capability, and the breadth of tumor markers it covers. However, a potential disadvantage might be its dependency on specialized chemiluminescence immunoassay analyzers, which may not be available in all medical laboratories.

Product Use in the Field

This test kit is primarily utilized in laboratory settings equipped with the appropriate analyzers. Technicians conduct the analyses by preparing blood samples and utilizing the chemiluminescence technology to detect and quantify tumor markers, offering early insights into potentially malignant conditions.

Recommendations

For optimal use, it is recommended to store the Tumor Test Marker YRA385 // YRA391 kits at temperatures between 2-8°C. Ensure regular calibration and maintenance of your chemiluminescence immunoassay analyzers to maintain accuracy. Don’t miss the opportunity to enhance your laboratory’s diagnostic power; request a quote or generate an automatic quotation through the Kalstein Plus platform.

Features

• Detection of 18 different tumor markers
• Early cancer detection capabilities
• Compatible with chemiluminescence immunoassay analyzers
• Available in various test kit sizes
• Covers major tumor markers like AFP, CEA, CA125, CA15-3, CA19-9, f-PSA, and t-PSA
• Certified with CE, ISO13485, FSC

Technical Specifications